Company News

Semex is pleased to announce its 2021-2022 Board of Directors with one new member, Normand Barriault, joining the Board, replacing outgoing director Jean Bissonnette, representing Centre d'insémination artificielle du Québec (CIAQ).   Phil MacLean will continue to serve as President of the Board (EastGen), assisted by Vice President Jean-François Morin (CIAQ) and Executive Member Curtis McNeil (EastGen). Other members of the Board of Directors include: Mariette Gagnon (CIAQ); Eric Iversen (WestGen); Richard Lagacé (CIAQ); Gerrit Wensink (EastGen); Tom Pasco (EastGen); and James Ross (WestGen).   Photo Caption: Top from L to R: Phil MacLean, Jean-François Morin, Curtis McNeil; Middle from L to R: Normand Barriault, Mariette Gagnon, Eric Iversen; Bottom from L to R: Richard Lagacé, Gerrit Wensink, Tom Pasco, James Ross                                                                          
... Read More...

Semex is pleased to announce that Phil MacLean (EastGen) has been appointed as President & Chairman of the Board for 2020-2021, succeeding Gary Bowers (CIAQ). Assisting Semex’s new President is Jean-François Morin (CIAQ) as Vice President and Gerrit Wensink (EastGen) as Executive Member of the Board.

 

 

Semex President Phil MacLean first joined the Semex Board in 2017, serving on the Audit & Risk Committee from 2017-2020. Representing Semex Partner Owner EastGen, he joined their board in 2016, and was elected Vice President in 2019 and 2020. A native of Nova Scotia, Phil’s farm spans 1300 acres and is a robot operation, now focused on developing an A2A2 herd following the dispersal of his 300-head registered herd, Headline Holsteins. Active in the dairy industry, Phil has served on the boards of the Dairy Farmers of Newfoundland and Labrador, as well as Dairy Farmers of Canada. Phil and his wife Pauline Duivenvoorden also operate Barn Fine Eggs, a 7800-laying hen operation as well as Farm Fine Brood, a 25,000-bird broiler operation. Extremely successful, they were awarded the Outstanding Young Farmers Atlantic Canada Award in 1999.    

 

 

 

 

Also serving on the Semex Board of Directors are:

 

 

 

 

Jean Bissonnette (CIAQ)

Mariette Gagnon (CIAQ)

Eric Iversen (WestGen)

Richard Lagacé (CIAQ)

Curtis McNeil (EastGen)

Tom Pasco (EastGen)

James Ross ... Read More...

The Semex Board of Directors and Executive Management Team is excited to announce the creation of a new wholly-owned subsidiary, Semex Mexico, effective October 1, 2020.

“The Mexican dairy industry has seen consistent, steady growth. This is driven by their consumers turning to new healthier dairy products and a growing cheese market, the formation of the Semex Mexico subsidiary is a natural progression of our business,” says Horacio Larrea, Semex Director International Sales & Business Development, Latin America. “Mexico has always been a key market for Semex, with the Mexican dairyman demanding the product, solutions and services Semex is known for worldwide.”

Leading Semex Mexico is Ing Ernesto Padilla de Anda, with seven years of experience working shoulder-to-shoulder with dairymen across Mexico. Ernesto will work with our distribution network around the country, ensuring that Semex’s very best products and programs will be available to Mexican farmers.  

Semex Mexico joins Semex USA, Semex UK, Semex Australia, Semex Argentina, Semex Uruguay, Genbank (Hungary), Semex Deutschland, Semex N.Z. Ltd and Semex China within the Semex-owned subsidiary companies. Along with Ernesto and his distributor network, Semex is committed to Semex Mexico’s future growth and success.

Semex is a leading global genetic company focused on providing our clients with the solutions, innovations and technologies that positively impact their lives, as well as the lives of the animals on their operations and within our global community. This is Genetics for Life, our guiding compass. For more information please visit www.semex.com. For more information on Semex Mexico please visit www.semex.com/mexico
... Read More...

Semex is saddened to announce the passing of one of the most globally popular sires of our time, Val-Bisson Doorman.
A one-of-a-kind bull, Doorman was one of the first bulls to greatly benefit from the advent of genomics. His non-genomic parent average gave him modest PTAT and GTPI figures, at breed average. But, with his genomic information, he was released as a proven sire in December 2015 at +4.59 PTAT with a +2439 GTPI, +4.2 PL and a low 2.51 SCS. This, with a pedigree virtually laced with Holstein royalty including Goldwyn, Prelude, Blackstar, Chief Mark, Shottle, Rudolph and Starbuck, it seemed Doorman was born to be the modern transmitter of elite type and show style.
"From the moment we introduced him as a Genomax® and Immunity+® sire, he was extremely popular - to the point that even though he was a good producer, he simply could not meet the extreme demand," says Brad Sayles, Semex Chief Operating Officer.
What truly lit the fire in Doorman sales, however, were his daughters. Initially breeders loved their calves and then came back wanting to use him again and again as his milking daughters arrived. With too many Grand Champions and Premier Sire awards to list, breeders everywhere appreciated his dominance regardless of venue or nation - Doorman was the modern Sire of Champions, a legacy to be felt for years upon years to come.
For more information on Semex please visit www.semex.com
... Read More...

The world is grappling with an issue of enormous scale and human impact, and our hearts go out to all who have been affected by the outbreak of coronavirus (COVID-19).   At Semex, we believe it is our role and responsibility during this time to prioritize the health and well-being of our global staff and clients. We have advised all of our locations and the entire Semex Family to follow the recommendations provided by their local health officials and government leaders working to contain this virus.   Right now, we’re working as normally as possible to ensure there is little to no disruption of services to our clients and partners worldwide. We are closely monitoring any changes and will continue to make decisions with vigilance and courage, informed by the latest science-based information and guided by Our Mission and Values.   For more information about COVID19 visit World Health Organization.
... Read More...

Gordon Miller, Sr. Vice President, Sales & Business Development, will retire after a storied career with Semex on April 2, 2020.

Gordon says, "Thirty years ago a very green city boy joined Semex UK as company accountant from the accountancy firm EY. I was this young man and I knew a bit about Semex as I had been involved in their audit for three years. It was the charismatic leadership of the Semex UK's owner Drew Sloan that attracted me to the company."

"When I joined I was not disappointed. Semex UK was a vibrant, forward-thinking company that was punching way above their weight with marketing ideas well ahead of their time. It was not a genetics company but a marketing company that just happened to sell genetics. The dairy industry was on a high, milk prices were strong and there was lots of margin in the semen business, not just in the UK but around the world."

"In September 2000 I left Semex for a good job in banking with RBS (Royal Bank of Scotland) and went on to manage the high-risk team for RBS dealing with distressed companies. It was a great experience and really taught me about what it took to run a successful business. Seven years later Paul Larmer asked me to rejoin Semex as Managing Director of Semex UK. It was a big decision to leave the bank, but I had unfinished business at Semex. I knew there were still great people at Semex UK and that Semex still had a great product. And, so it has proved! Under the leadership of Paul Larmer, Semex has changed dramatically."

"Six years ago I was asked by Paul to take on the leadership of our Global Sales Team first as VP, and then as Sr VP of Sales and Business Development. It has been an honour and a privilege to lead the Global Sales Team, seeing growth in each of these years. We have a great team of people who have responded to the changing market conditions we face and the ... Read More...

Semex firmly believes that its people are the cornerstone to its success, and is pleased to announce two key appointments to its embryo division effective immediately. These placements underpin its commitment to global growth and leading technology within its embryo division:      Dany-Pierre Rondeau has been named Vice President, Business Development Embryo Division. Reporting to Semex CEO Paul Larmer, Dany-Pierre will lead the growth of Semex's global embryo division, focusing on global business planning, market development and operational leadership.   Dany-Pierre joined Semex in 2013, progressively adding responsibilities to his portfolio of responsibilities within Semex's global sales team. In March 2018, Dany completed his MBA at Western's Ivey School of Business. Following this, in April 2018, Dany accepted the role of Director, International Sales & Business Development, managing Eastern Europe, the Middle East and Africa, and in 2019 expanded his involvement to Western Europe, overseeing 74 markets in total. During his tenure at Semex he has established new business in Vietnam and Indonesia and has led rapid sales growth in Russia and the Middle East.   Reporting to Dany-Pierre Rondeau, Dr. Shantille Kruse has been appointed Director, Boviteq US Business Development. Shantille has been with Boviteq in the US since July 2014, collaborating with veterinarians and clients, as well as supporting OPU/IVF services technical inquiries. Shantille was raised on a diversified livestock operation near Tecumseh, Nebraska, and earned her B.S. in Animal Science from the University of Nebraska, followed by her M.S. in Biomedical Science at the Animal Reproduction and Biotechnology Lab at Colorado State University. There, her research focused on improving cryopreservation techniques for both in vivo- and in vitro- produced bovine embryos. She earned her Ph.D. in Reproductive Physiology from the University of Minnesota ... Read More...

Semex is saddened to announce that global superstar 0200HO00560 Monument Impression has passed away.


 

Outcross sire, Impression arrived with a progeny proof in April 2013 as Semex's #1 new release sire. Six years later, his demand has never waned with sales to every corner of the Earth including Canada, the US, Germany, France, and Japan.

 

As one of the flagship Immunity+® sires, Impression's appeal knew no bounds! He was globally demanded because he sired healthy, long-lasting, profitable cows and ranked as the top sire of calves registered in Canada in 2016!

 

"His daughters were the kind that could virtually go unnoticed in herds," says Brad Sayles, Semex Chief Operating Officer. "That's why producers continued to use him again and again. Impressions do not get sick and just do their jobs day in and day out, just like we expect Immunity+ sires to do. Dairymen everywhere tell us they are their favorites because they're functional and easy to work with. Based on his 82% Good Plus and better rating on over 12,000 cows scored in Canada, we can definitely say they were appealing and will remain in herds for many, many lactations."

 

A 99% reliability sire, Impression's maternal line is dominated by the most popular sires of modern times including Durham, Lee and Bellwood, with his five closest dams being VG or EX. Impressions everywhere have been the beneficiary of his pedigree, as he's maintained solid type figures throughout his career, posting a +12 Conf and +2.02 PTAT in December 2019.

 

A limited amount of Impression semen remains. For more information on Impression, Semex or of its suite of solutions visit www.semex.com

... Read More...

The Semex lineup is truly designed to 'Crush Disease' with the addition of four Jersey and 29 Holstein Immunity+® sires in the December 2019 genetic evaluation. These additions have driven the active Immunity+ lineup to 245 sires! Exclusive to Semex, Immunity+ is the only proven genetic solution that improves herd health with the first generation, compounding with each subsequent generation. "Dairymen everywhere are serious about herd health," says Drew Sloan, Semex Vice President, International Sales. "Financial and social pressures are driving clients everywhere to look for a genetic solution. And, they're making health a primary selection goal. Our Immunity+ lineup is the only proven way to improve the strength of an animals' immune system and reduce disease and antibiotic usage. We're literally helping clients everywhere 'Crush Disease'."
"We've found that the environment doesn't really matter too much," says Dr Steven Larmer, Semex Senior Manager, Genomics Program. "When it comes to Immunity+, we see the same kind of results in dairies all around the world. We consistently see less mastitis, less mortality and less lameness. And, those are important economic drivers."
Leading the Immunity+ Holstein lineup in December is the new #19 GTPI sire, 0200HO10693 Siemers Bloomfield, at +2698 GTPI. He is the only bull in Holstein Association USA's Top 100 International Bulls' Top 20 listing, offering disease resistant genetics! A Delta x Numero Uno x Bombi, Bloomfield delivers +878 NM$, +1021 DWP$, +106 PTAF, +5.9 PL, +2.40 DPR with solid +2.24 PTAT.
Impressively, many of our top 10 LPI proven sires are also Immunity+® sires. The newest to the list is #9 LPI 0200HO10661 Stantons Adagio-P, making him the #1 New LPI Immunity+ sire! A Powerball-P x McCutchen x the Elly Mae family is +3381 GLPI and delivers impressive mammary systems, that are shallow with excellent quality and strong attachments. With over 200 ... Read More...

The best giveaway at World Dairy Expo now comes in brown! This year Semex is pleased to be giving away two Immunity+® sired heifers …. One Holstein, and for the first time ever, one Jersey!

“We’re extremely excited to be giving away both a Holstein and a Jersey calf this year,” says Michael Hurst, Semex Director, US Sales & Business Development. “They’re both by in-demand Immunity+ sires and are ready to go home and literally help you build a healthier herd from day one! We’re also giving away 10 Elevate® genomic tests each day and entry is simple… Just come to the Semex Tent!”

Launched in December 2012, Semex’s Immunity+ sire lineup has proven itself to be the only way to effectively crush disease with genetics. At 30% heritability and proven to reduce disease from 5-10% in just one generation with no genetic sacrifices, Immunity+ sires are improving herd health worldwide.

“Studies analyzing health data from over 30,000 cows and 75,000 heifers on 35 herds have shown reductions in every major disease ranging from 5-20% compared to other sires. We’re hearing from herds around the world every day about how healthy these animals are,” says Hurst. “And, with the 2018 launch of our female genomic testing program, Elevate, we can now access female Immunity genomics, providing us with the best way to crush disease and help our clients make more money every day.”

Semex invites all World Dairy Expo attendees to visit the Semex Tent, have fun in our photo booth with special props and prizes, and enter to win one of these calves and 10 free Elevate tests to be announced daily. Known as the ‘place to meet’ at World Dairy Expo Semex will once again be hosting hospitality hours from 5:00-7:00 pm on Thursday and Friday nights, with a live calf draw at 6:00 pm both nights. ... Read More...